Cite
HARVARD Citation
Oda, N. et al. (2022). Interstitial lung disease after receiving the mRNA-based COVID-19 vaccine tozinameran. Respiratory medicine case reports. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Oda, N. et al. (2022). Interstitial lung disease after receiving the mRNA-based COVID-19 vaccine tozinameran. Respiratory medicine case reports. p. . [Online].